Back
Matinas BioPharma Holdings Vs. Simulations Plus Industry Stock Comparison
Sell
22
MTNB
Matinas BioPharma Holdings
Last Price:
$0.59
Seasonality Move:
-7.09%
Sell
43
SLP
Simulations Plus
Last Price:
$32.67
Seasonality Move:
-0.28%
Sell
22
Matinas BioPharma Holdings (MTNB)
is a Sell
Is Matinas BioPharma Holdings a Buy, Sell or Hold?
-
The current Matinas BioPharma Holdings [MTNB] share price is $0.57. The Score for MTNB is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
-
MTNB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Simulations Plus (SLP)
is a Sell
Is Simulations Plus a Buy, Sell or Hold?
-
The current Simulations Plus [SLP] share price is $32.20. The Score for SLP is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
SLP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MTNB Stock Price Chart
What is Matinas BioPharma Holdings's stock price today?
-
The Matinas BioPharma Holdings share price today is $0.57The current trend is relatively stagnant and MTNB is experiencing slight selling pressure.
SLP Stock Price Chart
What is Simulations Plus's stock price today?
-
The Simulations Plus share price today is $32.20Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SLP is experiencing selling pressure, which indicates risk of future bearish movement.
MTNB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0 | Sell |
Relative Strength Index (14 RSI): | 51.95 | Buy |
Chaikin Money Flow: | -16885 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.53 - 0.57) | Buy |
Bollinger Bands (100): | (0.52 - 0.64) | Sell |
SLP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.98 | Buy |
Relative Strength Index (14 RSI): | 64.84 | Buy |
Chaikin Money Flow: | -411742 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (23.25 - 29.27) | Buy |
Bollinger Bands (100): | (26.34 - 33.44) | Buy |
MTNB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.54 | Buy |
20-day SMA: | 0.55 | Buy |
50-day SMA: | 0.57 | Sell |
200-day SMA: | 2.78 | Sell |
8-day EMA: | 0.55 | Buy |
20-day EMA: | 0.55 | Buy |
50-day EMA: | 0.6 | Sell |
200-day EMA: | 2.95 | Sell |
SLP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 29.02 | Buy |
20-day SMA: | 26.4 | Buy |
50-day SMA: | 29.36 | Buy |
200-day SMA: | 32.57 | Sell |
8-day EMA: | 30 | Buy |
20-day EMA: | 28 | Buy |
50-day EMA: | 28.48 | Buy |
200-day EMA: | 32.58 | Sell |
Matinas BioPharma Holdings Earnings Growth & MTNB Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.56 per share, and a decrease next year of $2.50 per share.
Simulations Plus Earnings Growth & SLP Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.11 per share, an increase this year of $0.56 per share, and an increase next year of $0.14 per share.
Matinas BioPharma Holdings Technical Analysis
Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Simulations Plus Technical Analysis
Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |